Bulletin
Investor Alert

Regeneron Pharmaceuticals Inc.

NAS: REGN

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 27, 2022, 7:58 p.m.

/zigman2/quotes/203149337/composite

$

692.61

Change

-0.19 -0.03%

Volume

Volume 33,535

Quotes are delayed by 20 min

/zigman2/quotes/203149337/composite

Previous close

$ 683.44

$ 692.80

Change

+9.36 +1.37%

Day low

Day high

$680.00

$693.81

Open

52 week low

52 week high

$497.22

$747.42

Open

Insider Actions for Regeneron Pharmaceuticals Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
05/17/2022 Andrew J. Murphy
EVP Research
57   Disposition at $670.49 per share. 38,217
05/17/2022 Andrew J. Murphy
EVP Research
153   Disposition at $669.12 per share. 102,375
05/17/2022 Andrew J. Murphy
EVP Research
180   Disposition at $668.68 per share. 120,362
05/17/2022 Andrew J. Murphy
EVP Research
154   Disposition at $667.49 per share. 102,793
05/17/2022 Andrew J. Murphy
EVP Research
352   Disposition at $666.23 per share. 234,512
05/17/2022 Andrew J. Murphy
EVP Research
126   Disposition at $665.36 per share. 83,835
05/17/2022 Andrew J. Murphy
EVP Research
428   Disposition at $664.32 per share. 284,328
05/17/2022 Andrew J. Murphy
EVP Research
472   Disposition at $663.6 per share. 313,219
05/17/2022 Andrew J. Murphy
EVP Research
779   Disposition at $662.57 per share. 516,142
05/17/2022 Andrew J. Murphy
EVP Research
465   Disposition at $661.46 per share. 307,578
05/17/2022 Andrew J. Murphy
EVP Research
77   Disposition at $660.32 per share. 50,844
05/17/2022 Andrew J. Murphy
EVP Research
123   Disposition at $658.56 per share. 81,002
05/17/2022 Andrew J. Murphy
EVP Research
60   Disposition at $657.51 per share. 39,450
05/17/2022 Andrew J. Murphy
EVP Research
58   Disposition at $656.52 per share. 38,078
05/17/2022 Andrew J. Murphy
EVP Research
59   Disposition at $655.4 per share. 38,668
05/16/2022 Andrew J. Murphy
EVP Research
6,457   Derivative/Non-derivative trans. at $648.31 per share. 4,186,137
05/16/2022 Andrew J. Murphy
EVP Research
10,000   Derivative/Non-derivative trans. at $179.13 per share. 1,791,300
05/02/2022 Arthur Frederick Ryan
Director
3   Disposition at $658.09 per share. 1,974
05/02/2022 Arthur Frederick Ryan
Director
3   Disposition at $656.97 per share. 1,970
05/02/2022 Arthur Frederick Ryan
Director
6   Disposition at $655.44 per share. 3,932
05/02/2022 Arthur Frederick Ryan
Director
1   Disposition at $654.21 per share. 654
05/02/2022 Arthur Frederick Ryan
Director
21   Disposition at $653.57 per share. 13,724
05/02/2022 Arthur Frederick Ryan
Director
14   Disposition at $652.71 per share. 9,137
05/02/2022 Arthur Frederick Ryan
Director
10   Disposition at $651.46 per share. 6,514
05/02/2022 Arthur Frederick Ryan
Director
6   Disposition at $650.47 per share. 3,902
05/02/2022 Arthur Frederick Ryan
Director
5   Disposition at $649.62 per share. 3,248
05/02/2022 Arthur Frederick Ryan
Director
4   Disposition at $648.68 per share. 2,594
05/02/2022 Arthur Frederick Ryan
Director
3   Disposition at $647.09 per share. 1,941
05/02/2022 Arthur Frederick Ryan
Director
7   Disposition at $646.49 per share. 4,525
05/02/2022 Arthur Frederick Ryan
Director
3   Disposition at $645.64 per share. 1,936
05/02/2022 Arthur Frederick Ryan
Director
9   Disposition at $644.54 per share. 5,800
05/02/2022 Arthur Frederick Ryan
Director
5   Disposition at $643.76 per share. 3,218
05/02/2022 Marion McCourt
EVP Commercial
1,100   Disposition at $656.97 per share. 722,667
05/02/2022 Marion McCourt
EVP Commercial
1,100   Derivative/Non-derivative trans. at $342.93 per share. 377,223
04/11/2022 Robert E. Landry
EVP Finance CFO
68   Disposition at $738.63 per share. 50,226
04/11/2022 Robert E. Landry
EVP Finance CFO
22   Disposition at $737.89 per share. 16,233
04/11/2022 Robert E. Landry
EVP Finance CFO
189   Disposition at $736.61 per share. 139,219
04/11/2022 Robert E. Landry
EVP Finance CFO
149   Disposition at $735.36 per share. 109,568
04/11/2022 Robert E. Landry
EVP Finance CFO
75   Disposition at $734.53 per share. 55,089
04/11/2022 Robert E. Landry
EVP Finance CFO
1,226   Disposition at $733.52 per share. 899,295
04/11/2022 Robert E. Landry
EVP Finance CFO
22   Disposition at $732.56 per share. 16,116
04/11/2022 Robert E. Landry
EVP Finance CFO
37   Disposition at $731.6 per share. 27,069
04/11/2022 Robert E. Landry
EVP Finance CFO
74   Disposition at $729.76 per share. 54,002
04/08/2022 Christopher Robert Fenimore
SVP Controller
3,451   Derivative/Non-derivative trans. at $736.21 per share. 2,540,660
04/08/2022 Christopher Robert Fenimore
SVP Controller
2,155   Derivative/Non-derivative trans. at $736.21 per share. 1,586,532
04/08/2022 Robert E. Landry
EVP Finance CFO
1,552   Derivative/Non-derivative trans. at $736.21 per share. 1,142,597
04/08/2022 Robert E. Landry
EVP Finance CFO
4,586   Derivative/Non-derivative trans. at $736.21 per share. 3,376,259
04/08/2022 Robert E. Landry
EVP Finance CFO
31   Disposition at $745.27 per share. 23,103
04/08/2022 Robert E. Landry
EVP Finance CFO
56   Disposition at $744.52 per share. 41,693
04/08/2022 Robert E. Landry
EVP Finance CFO
32   Disposition at $743.71 per share. 23,798
04/08/2022 Robert E. Landry
EVP Finance CFO
28   Disposition at $740.98 per share. 20,747
04/08/2022 Robert E. Landry
EVP Finance CFO
29   Disposition at $739.02 per share. 21,431
04/08/2022 Robert E. Landry
EVP Finance CFO
43   Disposition at $735.12 per share. 31,610
04/08/2022 Robert E. Landry
EVP Finance CFO
44   Disposition at $733.38 per share. 32,268
04/08/2022 Robert E. Landry
EVP Finance CFO
16   Disposition at $729.67 per share. 11,674
04/08/2022 Robert E. Landry
EVP Finance CFO
30   Disposition at $728.77 per share. 21,863
04/08/2022 Robert E. Landry
EVP Finance CFO
16   Disposition at $724.33 per share. 11,589
04/08/2022 Christopher Robert Fenimore
SVP Controller
5,000   Derivative/Non-derivative trans. at $270.43 per share. 1,352,150
04/08/2022 Christopher Robert Fenimore
SVP Controller
2,450   Derivative/Non-derivative trans. at $555.67 per share. 1,361,391
04/08/2022 Robert E. Landry
EVP Finance CFO
2,000   Derivative/Non-derivative trans. at $399.66 per share. 799,320
04/08/2022 Robert E. Landry
EVP Finance CFO
6,000   Derivative/Non-derivative trans. at $381.92 per share. 2,291,520
04/07/2022 Robert E. Landry
EVP Finance CFO
1,175   Derivative/Non-derivative trans. at $716.09 per share. 841,405
04/07/2022 Joseph J. LaRosa
EVP General Counsel and Secret
5,114   Disposition at $721.1 per share. 3,687,705
04/07/2022 Bonnie L. Bassler
Director
1,240   Disposition at $725 per share. 899,000
04/07/2022 Robert E. Landry
EVP Finance CFO
1,500   Derivative/Non-derivative trans. at $399.66 per share. 599,490
04/07/2022 Bonnie L. Bassler
Director
1,240   Derivative/Non-derivative trans. at $380.95 per share. 472,378
04/06/2022 Leonard S. Schleifer
President & CEO; Director
2,653   Disposition at $710.04 per share. 1,883,736
04/05/2022 Leonard S. Schleifer
President & CEO; Director
4,461   Disposition at $710.05 per share. 3,167,533
04/01/2022 Robert E. Landry
EVP Finance CFO
15   Disposition at $701.98 per share. 10,529
04/01/2022 Robert E. Landry
EVP Finance CFO
301   Disposition at $695.5 per share. 209,345
04/01/2022 Arthur Frederick Ryan
Director
3   Disposition at $701.82 per share. 2,105
04/01/2022 Arthur Frederick Ryan
Director
4   Disposition at $698.14 per share. 2,792
04/01/2022 Arthur Frederick Ryan
Director
7   Disposition at $697.39 per share. 4,881
04/01/2022 Arthur Frederick Ryan
Director
8   Disposition at $696.5 per share. 5,572
04/01/2022 Arthur Frederick Ryan
Director
14   Disposition at $695.46 per share. 9,736
04/01/2022 Arthur Frederick Ryan
Director
4   Disposition at $694.74 per share. 2,778
04/01/2022 Arthur Frederick Ryan
Director
4   Disposition at $693.69 per share. 2,774
04/01/2022 Arthur Frederick Ryan
Director
10   Disposition at $692.41 per share. 6,924
04/01/2022 Arthur Frederick Ryan
Director
10   Disposition at $691.34 per share. 6,913
04/01/2022 Arthur Frederick Ryan
Director
12   Disposition at $690.59 per share. 8,287
04/01/2022 Arthur Frederick Ryan
Director
3   Disposition at $689.42 per share. 2,068
04/01/2022 Arthur Frederick Ryan
Director
12   Disposition at $688.59 per share. 8,263
04/01/2022 Arthur Frederick Ryan
Director
3   Disposition at $687.45 per share. 2,062
04/01/2022 Arthur Frederick Ryan
Director
6   Disposition at $686.83 per share. 4,120
04/01/2022 Marion McCourt
EVP Commercial
1,000   Disposition at $701.82 per share. 701,820
04/01/2022 Joseph J. LaRosa
EVP General Counsel and Secret
15   Disposition at $701.82 per share. 10,527
04/01/2022 Joseph J. LaRosa
EVP General Counsel and Secret
124   Disposition at $698.26 per share. 86,584
04/01/2022 Joseph J. LaRosa
EVP General Counsel and Secret
64   Disposition at $697.35 per share. 44,630
04/01/2022 Joseph J. LaRosa
EVP General Counsel and Secret
254   Disposition at $696.54 per share. 176,921
04/01/2022 Joseph J. LaRosa
EVP General Counsel and Secret
305   Disposition at $695.36 per share. 212,084
04/01/2022 Joseph J. LaRosa
EVP General Counsel and Secret
259   Disposition at $694.56 per share. 179,891
04/01/2022 Joseph J. LaRosa
EVP General Counsel and Secret
567   Disposition at $693.92 per share. 393,452
04/01/2022 Joseph J. LaRosa
EVP General Counsel and Secret
195   Disposition at $692.54 per share. 135,045
04/01/2022 Joseph J. LaRosa
EVP General Counsel and Secret
641   Disposition at $691.44 per share. 443,213
04/01/2022 Joseph J. LaRosa
EVP General Counsel and Secret
250   Disposition at $690.51 per share. 172,627
04/01/2022 Joseph J. LaRosa
EVP General Counsel and Secret
218   Disposition at $689.43 per share. 150,295
04/01/2022 Joseph J. LaRosa
EVP General Counsel and Secret
799   Disposition at $688.59 per share. 550,183
04/01/2022 Joseph J. LaRosa
EVP General Counsel and Secret
497   Disposition at $687.41 per share. 341,642
04/01/2022 Joseph J. LaRosa
EVP General Counsel and Secret
557   Disposition at $686.26 per share. 382,246
04/01/2022 Joseph J. LaRosa
EVP General Counsel and Secret
369   Disposition at $685.71 per share. 253,026
04/01/2022 Marion McCourt
EVP Commercial
1,000   Derivative/Non-derivative trans. at $342.93 per share. 342,930
03/31/2022 Leonard S. Schleifer
President & CEO; Director
2,886   Disposition at $710.01 per share. 2,049,088
03/31/2022 Christopher Robert Fenimore
SVP Controller
6,857   Derivative/Non-derivative trans. at $700.99 per share. 4,806,688
03/31/2022 Christopher Robert Fenimore
SVP Controller
1,797   Derivative/Non-derivative trans. at $700.99 per share. 1,259,679
03/31/2022 Robert E. Landry
EVP Finance CFO
1,184   Derivative/Non-derivative trans. at $700.99 per share. 829,972
03/31/2022 Christopher Robert Fenimore
SVP Controller
10,000   Derivative/Non-derivative trans. at $270.43 per share. 2,704,300
03/31/2022 Christopher Robert Fenimore
SVP Controller
2,000   Derivative/Non-derivative trans. at $555.67 per share. 1,111,340
03/31/2022 Robert E. Landry
EVP Finance CFO
1,500   Derivative/Non-derivative trans. at $399.66 per share. 599,490

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
29 Purchases
149 Sales
162,286
179,815
Last 6 months
60 Purchases
264 Sales
817,510
653,482
Last 12 months
103 Purchases
556 Sales
2,213,168
2,169,834

Officers and Executives

Dr. P. Roy Vagelos
Chairman
Dr. Leonard S. Schleifer
Co-President, Chief Executive Officer & Director
Dr. George Damis Yancopoulos
Co-President, Director & Chief Scientific Officer
Ms. Patrice Gilooly
Senior VP-Quality Assurance & Operations
Mr. Robert E. Landry
Chief Financial Officer & Executive VP-Finance
Dr. Andrew J. Murphy
Executive Vice President-Research
Mr. Bob McCowan
Chief Information Officer & Senior VP-IT
Dr. Neil Stahl
Executive VP-Research & Development
Dr. David Weinreich
Senior Vice President-Global Clinical Development
Mr. Nouhad Husseini
Senior VP-Business Development
Mr. Gerald Underwood
Senior Vice President-Technical Operations
Dr. Kerry K. Reinertsen
Senior Vice President-Strategic Alliances
Mr. Daniel P. van Plew
EVP, GM-Industrial Operations & Product Supply
Ms. Beth F. Holly
Chief Compliance Officer & Senior Vice President
Dr. Alan Shuldiner
Vice President-Translational Genetics
Ms. Marion McCourt
Executive Vice President-Commercial
Mr. Mark Volpe
Senior Vice President-Tax
Mr. Christopher Robert Fenimore
Senior VP, Head-Accounting & Controller
Mr. Mark Hudson
Head-Investor Relations
Ms. Sally A. Paull
Senior Vice President-Human Resources
Mr. Joseph J. LaRosa
Secretary, Executive VP & General Counsel
Ms. Maya Bermingham
Senior VP, Public Policy & Government Affairs
Dr. Ned Braunstein
SVP-Regulatory Affairs & Global Patient Safety
Dr. Michael S. Brown
Independent Director
Dr. Joseph L. Goldstein
Independent Director
Mr. George L. Sing
Independent Director
Mr. Arthur Frederick Ryan
Independent Director
Ms. Christine A. Poon
Independent Director
Dr. Marc Tessier-Lavigne
Independent Director
Dr. Bonnie L. Bassler
Independent Director
Dr. Huda Y. Zoghbi
Independent Director
Dr. N. Anthony Coles
Independent Director
Link to MarketWatch's Slice.